Cojutti P.G.; Candoni A.; Lazzarotto D.; Fili C.; Zannier M.; Fanin R.; Pea F., Population pharmacokinetics of continuous-infusion meropenem in febrile neutropenic patients with hematologic malignancies: Dosing strategies for optimizing empirical treatment against enterobacterales and p. aeruginosa, «PHARMACEUTICS», 2020, 12, Article number: 785 , pp. 1 - 11 [Scientific article]Open Access
Cojutti P.G.; Lazzarotto D.; Candoni A.; Dubbini M.V.; Zannier M.E.; Fanin R.; Pea F., Real-Time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: Results from a prospective, monocentric, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2020, 75, pp. 3029 - 3037 [Scientific article]Open Access
Cojutti, P.G.; Carnelutti, A.; Mattelig, S.; Sartor, A.; Pea, F., Real-Time Therapeutic Drug Monitoring-Based Pharmacokinetic/Pharmacodynamic Optimization of Complex Antimicrobial Therapy in a Critically Ill Morbidly Obese Patient. Grand Round/A Case Study, «THERAPEUTIC DRUG MONITORING», 2020, 42, pp. 349 - 352 [Scientific article]
Brancaccio, Gabriella; Pea, Federico; Moscarella, Elvira; Argenziano, Giuseppe, Sonidegib for the Treatment of Advanced Basal Cell Carcinoma, «FRONTIERS IN ONCOLOGY», 2020, 582866, pp. 1 - 7 [Scientific article]Open Access
Pea F., Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populations, «JOURNAL OF INFECTION AND CHEMOTHERAPY», 2020, 26, pp. 900 - 907 [Scientific article]
Soriano A.; Rossolini G.M.; Pea F., The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs), «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2020, 18, pp. 415 - 422 [Scientific article]Open Access
Vena A.; Munoz P.; Mateos M.; Guinea J.; Galar A.; Pea F.; Alvarez-Uria A.; Escribano P.; Bouza E., Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?, «INFECTIOUS DISEASES AND THERAPY», 2020, 9, pp. 137 - 149 [Scientific article]Open Access
Guaraldi G.; Milic J.; Cozzi-Lepri A.; Pea F.; Mussini C., Tocilizumab in COVID-19: finding the optimal route and dose – Authors' reply, «THE LANCET. RHEUMATOLOGY», 2020, 2, pp. E739 - E740 [Comment or similar]
Guaraldi G.; Meschiari M.; Cozzi-Lepri A.; Milic J.; Tonelli R.; Menozzi M.; Franceschini E.; Cuomo G.; Orlando G.; Borghi V.; Santoro A.; Di Gaetano M.; Puzzolante C.; Carli F.; Bedini A.; Corradi L.; Fantini R.; Castaniere I.; Tabbi L.; Girardis M.; Tedeschi S.; Giannella M.; Bartoletti M.; Pascale R.; Dolci G.; Brugioni L.; Pietrangelo A.; Cossarizza A.; Pea F.; Clini E.; Salvarani C.; Massari M.; Viale P.L.; Mussini C., Tocilizumab in patients with severe COVID-19: a retrospective cohort study, «THE LANCET. RHEUMATOLOGY», 2020, 2, pp. e474 - e484 [Scientific article]
Vanino E.; Tadolini M.; Attard L.; Cascavilla A.; Pea F.; Viale P., A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care, «INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE», 2019, 23, pp. 1042 - 1043 [Comment or similar]
Giacobbe D.R.; De Rosa F.G.; Del Bono V.; Grossi P.A.; Pea F.; Petrosillo N.; Rossolini G.M.; Tascini C.; Tumbarello M.; Viale P.; Bassetti M., Ceftobiprole: drug evaluation and place in therapy, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2019, 17, pp. 689 - 698 [Scientific article]Open Access
Pea F.; Krause R.; Muller C.; Hennart B.; Richardson M.; Meinitzer A.; Wiesen M.H.J.; Wiktorowicz T.; Spickermann J.; Henriksen A.S., Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays among European Laboratories, «THERAPEUTIC DRUG MONITORING», 2019, 41, pp. 657 - 664 [Scientific article]
Cojutti, Pier Giorgio; Maximova, Natalia; Schillani, Giulia; Hope, William; Pea, Federico, Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 1648 - 1655 [Scientific article]
Cojutti P.G.; Merelli M.; Bassetti M.; Pea F., Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: Findings from a monocentric, prospective, open-label, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 3588 - 3595 [Scientific article]
Crass R.L.; Cojutti P.G.; Pai M.P.; Pea F., Reappraisal of linezolid dosing in renal impairment to improve safety, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2019, 63, pp. 1 - 9 [Scientific article]
